These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
642 related items for PubMed ID: 30896792
1. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review). Chen C, Tang X, Liu Y, Zhu J, Liu J. Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792 [Abstract] [Full Text] [Related]
2. Dysregulation of non-coding RNAs in gastric cancer. Yang Q, Zhang RW, Sui PC, He HT, Ding L. World J Gastroenterol; 2015 Oct 21; 21(39):10956-81. PubMed ID: 26494954 [Abstract] [Full Text] [Related]
6. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma. Wei L, Wang X, Lv L, Liu J, Xing H, Song Y, Xie M, Lei T, Zhang N, Yang M. Mol Cancer; 2019 Oct 25; 18(1):147. PubMed ID: 31651347 [Abstract] [Full Text] [Related]
7. Exosomal non‑coding RNAs: Novel biomarkers with emerging clinical applications in gastric cancer (Review). Lu X, Zhang Y, Xie G, Ding Y, Cong H, Xuan S. Mol Med Rep; 2020 Nov 25; 22(5):4091-4100. PubMed ID: 33000279 [Abstract] [Full Text] [Related]
8. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression. Ahadi A. IUBMB Life; 2020 May 25; 72(5):884-898. PubMed ID: 32078236 [Abstract] [Full Text] [Related]
9. Long noncoding RNAs in gastric cancer carcinogenesis and metastasis. Nasrollahzadeh-Khakiani M, Emadi-Baygi M, Schulz WA, Nikpour P. Brief Funct Genomics; 2017 May 01; 16(3):129-145. PubMed ID: 27122631 [Abstract] [Full Text] [Related]
10. Impact of MiRNAs and LncRNAs on Multidrug Resistance of Gastric Cancer. Wu Y, Yang X, Xie Z, Hu H, Lei X, Niu D, Li S, Tuo L. Comb Chem High Throughput Screen; 2022 May 01; 25(13):2127-2140. PubMed ID: 35366768 [Abstract] [Full Text] [Related]
11. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review. Huang YK, Yu JC. World J Gastroenterol; 2015 Sep 14; 21(34):9863-86. PubMed ID: 26379393 [Abstract] [Full Text] [Related]
12. Non‑coding RNAs that regulate the Wnt/β‑catenin signaling pathway in gastric cancer: Good cop, bad cop? (Review). Shao Z, Gao D, Chen L, Ding W, Yu Q. Oncol Rep; 2020 Oct 14; 44(4):1314-1321. PubMed ID: 32945460 [Abstract] [Full Text] [Related]
13. The functional sites of miRNAs and lncRNAs in gastric carcinogenesis. Wan X, Ding X, Chen S, Song H, Jiang H, Fang Y, Li P, Guo J. Tumour Biol; 2015 Feb 14; 36(2):521-32. PubMed ID: 25636450 [Abstract] [Full Text] [Related]
14. Non-coding RNA in drug resistance of hepatocellular carcinoma. Ding B, Lou W, Xu L, Fan W. Biosci Rep; 2018 Oct 31; 38(5):. PubMed ID: 30224380 [Abstract] [Full Text] [Related]
15. Long noncoding RNAs: novel insights into gastric cancer. Fang XY, Pan HF, Leng RX, Ye DQ. Cancer Lett; 2015 Jan 28; 356(2 Pt B):357-66. PubMed ID: 25444905 [Abstract] [Full Text] [Related]
16. Long Noncoding RNAs: New Regulators of Resistance to Systemic Therapies for Gastric Cancer. Sun W, Jiang C, Ji Y, Xiao C, Song H. Biomed Res Int; 2021 Jan 28; 2021():8853269. PubMed ID: 33506041 [Abstract] [Full Text] [Related]
17. Long noncoding RNA BLACAT1 modulates ABCB1 to promote oxaliplatin resistance of gastric cancer via sponging miR-361. Wu X, Zheng Y, Han B, Dong X. Biomed Pharmacother; 2018 Mar 28; 99():832-838. PubMed ID: 29710482 [Abstract] [Full Text] [Related]
18. The emerging role of noncoding RNAs in colorectal cancer chemoresistance. Wei L, Wang X, Lv L, Zheng Y, Zhang N, Yang M. Cell Oncol (Dordr); 2019 Dec 28; 42(6):757-768. PubMed ID: 31359293 [Abstract] [Full Text] [Related]